Last reviewed · How we verify

NCT06352112

Effects of the Hypopressive Exercises in Women With Pelvic Organ Prolapse

Completed NA Last updated 10 April 2024
What this trial tests

NA trial testing Pelvic Floor Muscle Training in Pelvic Floor Disorders in 32 participants. Completed in 15 February 2024.

Timeline
15 March 2023
Primary endpoint
15 January 2024
15 February 2024

Quick facts

Lead sponsorHacettepe University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment32
Start date15 March 2023
Primary completion15 January 2024
Estimated completion15 February 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 20 to 50, female only, with Pelvic Floor Disorders or Prolapse; Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was compare home-based pelvic floor muscle training (PFMT) alone and home-based PFMT combined with hypopressive exercise (HE) in terms of pelvic floor muscle (PFM) activation and severity of pelvic floor dysfunction (PFD) in women with pelvic organ prolapse (POP) for eight weeks. For this purpose, the participants were randomly divided into two groups: \[PFMT alone (n:15) and PFMT combined with HE(n:17)\]. DuoBravo EMG device for evaluation of PFM activation and "Pelvic Floor Distress Inventory-20" was used to evaluate the severity of PFD. All evaluations were performed twice in total, at baseline and at week 8.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Pelvic Floor Muscle Training

Trials testing the same drug.

Other recruiting trials for Pelvic Floor Disorders

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06352112.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing